Eden Research plc
LSE : EDE

June 16, 2011 06:44 ET

Co-encapsulation development agreement

                                                                                          16 June 2011
                                                                             GB0001646941/GBP/PLUS-exn
                                                   
                                           EDEN RESEARCH PLC
                                         ("Eden" or "Company")
                                Co-encapsulation development agreement

Eden  Research  plc, a leading UK agrochemical and encapsulation development company,  is  pleased  to
announce  that it has signed a development agreement with Tagros Chemicals India PVT Limited  ("PVT"),
based in Tamil Nadu, India.

Tagros  is  one of India's leading manufacturers and exporters of a range of agrochemicals offering  a
range  of  high  value  Synthetic  Pyrethroids, Pesticide  Intermediates  and  Fungicides.  Tagros  is
particularly  strong in Public Health Insecticides, where many of its formulations are  accredited  by
the WHO (World Health Organisation).

The agreement grants Tagros the right to use Eden's terpene encapsulation system to co-encapsulate one
of  Tagros'  important crop molecules, used in agricultural as well as Public Health, with  blends  of
synergistic terpenes.

Following  the development period provided under the agreement, Eden will then look to  enter  into  a
full licensing agreement with Tagros.

Clive  Newitt, Managing Director of Eden, said, "This is the second 'co-encapsulation' agreement  that
Eden has now entered into, following the SBM Developpement deal announced in December last year.

These  types of arrangements are very attractive to Eden as they present a significant opportunity  to
commercialise Eden's encapsulation technologies based upon products that are already being sold within
the global agrochemical industry, and at minimal cost to Eden.

Using  the  encapsulation system will allow Tagros to create new products that will  exhibit  a  wider
spectrum of activity, longer persistence and be less prone to resistance development."

The Directors of Eden are responsible for the contents of this announcement.

Enquiries:

Eden Research plc                                                        01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                           020 7368 6959
Mark Anwyl

Notes:
Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation
technology  for  agricultural  and  non-agricultural  uses  through  appropriate  regional  or  global
partnerships.

Terpenes  are  natural  compounds which function as defence mechanisms in many plant  groups  and  are
released in response to infection, attack by pests, stress or mechanical injury. Terpenes are  already
widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically,  terpenes  have  had  limited commercial use in the agrochemical  sector  due  to  their
volatility,  phytotoxicity and poor solubility. Eden's platform encapsulation technology provides  the
unique,  natural  solution to these problems and enables terpenes to be used  as  effective,  low-risk
agrochemicals.


For more information about Eden, please visit www.edenresearch.com


For more information about Tagros, please visit www.tagros.com

Contact Information

  • Eden Research plc